| Hans-Günter Meyer-Thompson | Hepatitiden
New drug ‘functionally cures’ many hepatitis B virus infections
New drug ‘functionally cures’ many hepatitis B virus infections
GSK’s “bepi” performs better than expected in efficacy trials, but its global impact is likely limited. (Science, 28.05.2026)